Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy
2019 · npj Breast Cancer · 136 citations
https://doi.org/10.1038/s41523-019-0108-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
746
Citations
10
h-index
10
i10-index
Muhammad Ali is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Liver Disease Diagnosis and Treatment & Hepatitis C virus research. The author has an h-index of 10, co-authored 12 publications.
ORCID: 0000-0001-8964-4416https://doi.org/10.1038/s41523-019-0108-8
https://doi.org/10.1038/s43018-023-00642-8
Click to start Chat